Multi-label classification of chronically ill patients with bag of words and supervised dimensionality reduction algorithms  by Bromuri, Stefano et al.
Journal of Biomedical Informatics 51 (2014) 165–175Contents lists available at ScienceDirect
Journal of Biomedical Informatics
journal homepage: www.elsevier .com/locate /y jb inMulti-label classiﬁcation of chronically ill patients with bag of words and
supervised dimensionality reduction algorithmshttp://dx.doi.org/10.1016/j.jbi.2014.05.010
1532-0464/ 2014 Elsevier Inc. All rights reserved.
⇑ Corresponding author.
E-mail address: stefano.bromuri@hevs.ch (S. Bromuri).Stefano Bromuri a,⇑, Damien Zufferey a, Jean Hennebert b, Michael Schumacher a
aUniversity of Applied Sciences Western Switzerland, Institute of Business Information Systems, TechnoArk 3, CH-3960 Sierre, Switzerland
bUniversity of Applied Sciences Western Switzerland, Institute of Information and Communication Technologies, Bd de Pérolles 80, CH-1705 Fribourg, Switzerland
a r t i c l e i n f o a b s t r a c tArticle history:
Received 30 October 2013
Accepted 19 May 2014
Available online 29 May 2014
Keywords:
Multi-label classiﬁcation
Complex patient
Diabetes type 2
Clinical data
Dimensionality reduction
Kernel methodsObjective: This research is motivated by the issue of classifying illnesses of chronically ill patients for
decision support in clinical settings. Our main objective is to propose multi-label classiﬁcation of
multivariate time series contained in medical records of chronically ill patients, by means of quantization
methods, such as bag of words (BoW), and multi-label classiﬁcation algorithms. Our second objective is to
compare supervised dimensionality reduction techniques to state-of-the-art multi-label classiﬁcation
algorithms. The hypothesis is that kernel methods and locality preserving projections make such
algorithms good candidates to study multi-label medical time series.
Methods: We combine BoW and supervised dimensionality reduction algorithms to perform multi-label
classiﬁcation on health records of chronically ill patients. The considered algorithms are compared with
state-of-the-art multi-label classiﬁers in two real world datasets. Portavita dataset contains 525 diabetes
type 2 (DT2) patients, with co-morbidities of DT2 such as hypertension, dyslipidemia, and microvascular
or macrovascular issues. MIMIC II dataset contains 2635 patients affected by thyroid disease, diabetes
mellitus, lipoid metabolism disease, ﬂuid electrolyte disease, hypertensive disease, thrombosis, hypoten-
sion, chronic obstructive pulmonary disease (COPD), liver disease and kidney disease. The algorithms are
evaluated using multi-label evaluation metrics such as hamming loss, one error, coverage, ranking loss, and
average precision.
Results: Non-linear dimensionality reduction approaches behave well on medical time series quantized
using the BoW algorithm, with results comparable to state-of-the-art multi-label classiﬁcation
algorithms. Chaining the projected features has a positive impact on the performance of the algorithm
with respect to pure binary relevance approaches.
Conclusions: The evaluation highlights the feasibility of representing medical health records using the
BoW for multi-label classiﬁcation tasks. The study also highlights that dimensionality reduction algo-
rithms based on kernel methods, locality preserving projections or both are good candidates to deal with
multi-label classiﬁcation tasks in medical time series with many missing values and high label density.
 2014 Elsevier Inc. All rights reserved.1. Introduction
The average lifespan has increased considerably due to the
invention of better drugs and improvement of healthcare, but the
rate of chronic illnesses per patient has also increased, becoming
a burden for the economy of industrialized and emerging countries
[1].
The interaction between chronic illnesses and multiple drugs
intake make the patient treatment complex to handle for caregiv-
ers. The possibility of taking informed decisions about complexpatients is important to slow down the development of their
illnesses.
Unfortunately, doctors have to take decisions whose
consequences will be evaluated only after years of treatment.
Furthermore, given the growth in number of chronically ill
patients, caregivers are often in charge of hundreds of patients
[2]. In addition, patient electronic health records (EHR) often con-
tain the evolution in time of the patient clinical data, which are
high dimensional multivariate time series of physiological values.
As reported in [3], physicians would use services that improve
their understanding of an illness even if these involve more
cognitive effort than in the standard practice. In particular, in the
medical informatics and data mining community [4,5] it has
already been discussed that classifying patients given their
1 www.portavita.eu.
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decision making process.
This paper is motivated by the problem of classifying patients
affected by multiple illnesses to enhance the decision support of
medical doctors. There are two challenges to overcome in order
to deﬁne a system capable to correctly classify the multiple
illnesses that may affect a chronically ill patient: (a) dealing with
irregular multivariate time series; and (b) dealing with the interac-
tion of multiple co-morbidities in a heterogeneous population of
patients.
The presence of high dimensional and multivariate data
presents a big challenge to standard classiﬁcation algorithms due
to the curse of dimensionality [6]. Clinical time series are often
irregular, a patient may present different number of records with
respect to another patient and the periods of time in which the val-
ues are collected may not be aligned. The challenge is even more
difﬁcult if we consider the inherently multi-label properties of
medical data, where a patient may present multiple co-morbidities
at once.
Concerning irregular time series, quantization algorithms, such
as the Bag of Words (BoW) model, have proven successful in sev-
eral medical tasks [7].
As a matter of fact, BoW is often used in biomedical time series.
In [7], Wang et al. present an application of the BoW model to EEG
and ECG signals. Similarly to us, the authors of [7] are faced with
the issue of time series of different length with possibly heteroge-
neous patients at hand.
Jiu et al. present a supervised approach towards BoW codebook
generation using neural networks in [8]. In particular, the approach
uses Multi-Layer Perceptrons (MLP) and the backpropagation
algorithm to update the weights of the codewords according to
their discrimination capabilities with respect to a set of classes.
Similarly to [8], in [9] Ordonez et al. present a modiﬁcation of
the BoW model to classify medical time series. Such a model uses
continuous multivariate time series to compute a symbolic repre-
sentation of the signals that is then used as the codebook for the
classiﬁcation of the patients.
Concerning multi-label classiﬁcation algorithms, an extensive
review can be found in [10]. Multi-label learning [11] implies
training sets where each instance has a labelset and the task is to
predict the labelset of unseen instances. As reported in [10], there
exist works that combine supervised dimensionality reduction
with multi-label learning [12–14]. Furthermore, most of these
works focus on applying multi-label techniques on text analysis
with static datasets [15].
In general terms multi-label classiﬁcation of complex patients
in discrete medical time series is quite an unexplored issue. Firstly,
we think that the main contribution of this paper is to propose the
combination of BoW, to quantize irregular time series present in
patient health records, and multi-label classiﬁcation algorithms,
to classify the chronic illnesses that a patient may present. These
are two established techniques, but in medical settings their com-
bination is quite novel.
Secondly, we believe that this contribution is interesting to
biomedical informatics as we evaluate linear and non-linear super-
vised dimensionality reduction approaches with respect to multi-
label classiﬁcation in medical time series, and we compare these
approaches with state-of-the-art multi-label classiﬁcation algo-
rithms. In doing this, we aim at identifying the most effective
supervised dimensionality reduction techniques with respect to
medical time series. We aim to conﬁrm the hypothesis that, given
the nature of the data at hand, non-linear supervised dimensional-
ity reduction algorithms have a behavior comparable to state of the
art multi-label classiﬁers.
Thirdly, our contribution is also of interest to biomedical
research because we perform our evaluation against two realworld medical datasets: the Portavita dataset, provided for this
study by the Portavita company,1 containing 525 diabetic patients
presenting, sometimes simultaneously, hypertension, dyslipidemia
or microvascular and macrovascular complications of diabetes type
2 (DT2) [16]; an extraction of 2635 patients from the public MIMIC
II database [17], where we consider patients affected simultaneously
by thyroid disease, diabetes mellitus, lipoid metabolism disease,
ﬂuid electrolyte disease, hypertensive disease, thrombosis, hypoten-
sion, chronic obstructive pulmonary disease (COPD), liver disease
and kidney disease.
The rest of this paper is organized as follows: Section 2 presents
a background on multi-label classiﬁcation, kernel methods, and
supervised dimensionality reduction algorithms; Section 3 pre-
sents the Portavita and MIMIC II datasets and their properties; Sec-
tion 4 presents the training schema for the attempted multi-label
classiﬁcation algorithms; Section 5 presents an evaluation for the
multi-label algorithms considered in this paper; ﬁnally, Section 6
concludes this paper and draws the lines for future work.
2. Background
In this Section we present the concepts of multi-label classiﬁca-
tion, kernels, locality preserving projections and multi-class Fisher
discriminant analysis. In Section 4 we show how we combined
these concepts in a system for classiﬁcation of multi-label chroni-
cally ill patients.
2.1. Multi-label classiﬁcation
Let X be the domain of observations and let L be the ﬁnite set
of labels. Given a training set T ¼ fðx1;Y1Þ; ðx2;Y2Þ; . . . ;
ðxn;YnÞg ðxi 2 X;Yi# LÞ i.i.d. drawn from an unknown distribution
D, the goal is to learn a multi-label classiﬁer h : X ! 2L. However,
it is often more convenient to learn a real-valued scoring function
of the form f : X  L ! R. Given an instance xi and its associated
label set Yi, a working system will attempt to produce larger values
for labels in Yi than those that are not in Yi, i.e. f ðxi; y1Þ > f ðxi; y2Þ
for any y1 2 Yi and y2 R Yi. By the use of the function f ð; Þ, we
can obtain a multi-label classiﬁer: hðxiÞ ¼ fyjf ðxi; yÞ > d; y 2 Lg,
where d is a threshold to infer from the training set. The function
f ð; Þ can also be adapted to a ranking function rankf ð; Þ, which
maps the outputs of f ðxi; yÞ for any y 2 L to f1;2; . . . ; jLjg such that
if f ðxi; y1Þ > f ðxi; y2Þ then rankf ðxi; y1Þ < rankf ðxi; y2Þ.
Furthermore, there exist several approaches to train multi-label
classiﬁers (see [10] for a comprehensive review on the subject).
The simplest approach, known as binary relevance (BR), is to train
one binary classiﬁer per label with traditional classiﬁcation algo-
rithms, considering each label as a separated problem. BR has the
disadvantage of not taking into consideration the relationships
existing amongst labels. To overcome this issue, several ensemble
methods have been deﬁned in the past, amongst which the most
popular ones are classiﬁer chains (CC) and label powersets
approaches (LP). CC methods work by recursively training classiﬁ-
ers with the label predicted by the previous classiﬁer as new
features. LP methods focus on training classiﬁers deﬁning classes
by means of subsets of the labelset. Despite having been demon-
strated effective, CC and LP methods present computational disad-
vantages with respect to BR methods, whose complexity is linear in
respect to the number of labels. In addition, CC methods are
difﬁcult to train with classiﬁer presenting many parameters, as
each classiﬁer in the chain needs to be optimized differently. Sec-
ondly, LP method are computationally infeasible due to the large
number of possible classes in a labelset.
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and their dependencies within a neighborhood to tune the
classiﬁer output. MLkNN [18] is a successful example of such a
method.
Within this paper we will show the effect of using dimensional-
ity reduction algorithms with a BR approach, considering the out-
put of each classiﬁer as separated, or as CC classiﬁers by
concatenating the projected features.
2.2. Kernels
Non-linear subspaces may be suitable to describe clinical data-
sets as due to their high dimensionality they may lie in complex
manifolds. Therefore, we may need to map our input data in terms
of clinical datasets to a higher dimensional space using a lineariza-
tion function. If we consider a set of m samples x1; x2; . . . ; xm 2 Rn,
belonging to c classes, then we can consider a non-linear mapping
/ : Rn ! F , where we choose / so that h/ðxiÞ;/ðxjÞi ¼ Kðxi; xjÞ,
where Kð; Þ is a positive semi-deﬁnite kernel function.
Performing this map explicitly can be computationally expen-
sive, to avoid it we can apply the Kernel Trick [19], and calculate
the Gram matrix Kð; Þ, containing the inner product between the
input vectors in the linearization space. This then allows us to
modify linear techniques using the inner product with appropriate
kernel functions, opening up the possibility of applying well
known approaches in non-linear spaces.
Within this paper we will use the RBF kernel and the histogram
intersection kernel [20]. The RBF kernel is deﬁned as:
Kðx; yÞ ¼ exp
kxyk2
2r2
ð1Þ
The histogram intersection kernel can be deﬁned starting from two
histograms x and y consisting both of m features. We denote the ith
features of x as xi and for y as yi. Then we can deﬁne the kernel as:
Kðx; yÞ ¼
Xm
i
minðxi; yiÞ ð2Þ
A big advantage of this kernel is that it is parameterless.
2.3. Locality preserving projections
As explained in [21], a LPP projection is a linear transformation
for which the data residing in a space Rn are mapped in a subspace
Rr , with r < n, such that nearby data pairs in the original
n-dimensional space are also close in the identiﬁed subspace. More
formally, if we consider a square matrix A 2 Rdd, where Ai;j 2 ½0;1,
representing the afﬁnity between the elements xi and xj in a
dataset with d elements, the TLPP transformation matrix can be
deﬁned as follows:
TLPP ¼ arg min
T2Rdr
1
2
Xn
i;j¼1
Ai;jkTTxi  TTxjk2
 !
ð3Þ
Within this paper we are interested in the usage of such a projec-
tion within the KLFDA technique, further details on how to calculate
TLPP can be found in [21].
2.4. Linear discriminant analysis and local linear discriminant analysis
Linear Discriminant Analysis (LDA) [22] is a widely used super-
vised dimensionality reduction technique that can ﬁnd the linear
transformation which best separates elements of different classes.
To achieve this, LDA makes use of the within-class scatter matrix
SðwÞ and of the between-class scatter matrix SðbÞ. These can be
deﬁned as:SðwÞ ¼
XC
i¼1
X
x2Ei
ðx liÞðx liÞT ð4Þ
where li is the mean of class Ei, and
SðbÞ ¼
XC
i¼1
Niðli  lÞðli  lÞT ð5Þ
where l is the global mean and Ni is the number of elements
belonging to class Ei. S
ðwÞ is a measure of the variance between
the elements belonging to the same class, while SðbÞ is a measure
of the variance of the elements belonging to different classes.
Ideally, we want the scatter to be minimized for elements of the
same class and maximized for elements of different classes. The
transformation matrix TLDA that achieves this is deﬁned as:
TLDA ¼ arg maxdetðT
TSðwÞTÞ
detðTTSðbÞTÞ
ð6Þ
As explained in [23], to specify a Locality Sensitive LDA (LSDA), we
can deﬁne the local within-class scatter matrix eSðwÞ and the local
between class scatter matrix eSðbÞ
eSðwÞ ¼ 1
2
Xn
i;j¼1
fW ðwÞi;j ðxi  xjÞðxi  xjÞT ð7Þ
eSðbÞ ¼ 1
2
Xn
i;j¼1
fW ðbÞi;j ðxi  xjÞðxi  xjÞT ð8Þ
where
fW ðwÞi;j ¼ Ai;j=Ni if yi ¼ yj ¼ c;0 if yi – yj
(
ð9Þ
fW ðbÞi;j ¼ Ai;jð1=N  1=NiÞ if yi ¼ yj ¼ c;1=N if yi – yj
(
ð10Þ
which implies that we are weighting the pairwise values according
to their afﬁnity matrix Ai;j 2 ½0;1, with Ai;j closer to 1 if xj is close to
xi and to 0 if they are far apart.
Then, the objective function can be expressed again as a
generalized eigenvalue problem:
TLSDA ¼ arg max
T2Rdr
trððTTeSðwÞTÞ1TTeSðbÞTÞÞh i ð11Þ
we refer the interested reader to [23], for further details on how to
compute LSDA.
2.5. Kernel local Fisher discriminant analysis
KLFDA [23] is a generalization of the previously presented LSDA
using kernel functions. If we consider eS/b ; eS/w and eS/t as the local
between-class, within-class and total scatter matrices respectively
in the space identiﬁed by a kernel mapping, then KLFDA seeks to
ﬁnd:
Topt ¼ arg max T
TeS/b T
TTeS/wT ¼ arg max T
TeS/b T
TTeS/t T ð12Þ
We can justify the use of supervised techniques based on LPP and
kernel methods with the considerations in [21], for which LPP is
particularly useful in applications where by preserving the struc-
ture of the neighborhood in the lower dimensional space, nearest
neighbor based approaches can still perform well, and the curse
of dimensionality is mitigated. Kernel methods are useful in cases
where the classes are non-linearly separable. In our case, we apply
the version of KLFDA speciﬁed in [23] using regularization.
168 S. Bromuri et al. / Journal of Biomedical Informatics 51 (2014) 165–1753. Materials
In this Section, we present the descriptive statistics of the two
datasets taken into consideration. For multi-label datasets,
amongst the descriptive statistics it is important to also consider
label cardinality and label density. Given a dataset D, and a set of
labels L, where the labels of an example are denoted with Yi we
can deﬁne label cardinality and label density as below.
Label Cardinality: Label cardinality of a dataset D is the average
number of labels of the examples in D:
LCðDÞ ¼ 1jDj
XjDj
i¼1
jYij ð13Þ
Label Density: Label density of D is the average number of
labels of the examples in D divided by jLj
LDðDÞ ¼ 1jDj
XjDj
i¼1
jYij
jLj ð14Þ
Label cardinality quantiﬁes the average number of alternative labels
that characterize the examples in the dataset. With respect to label
cardinality, label density also considers the number of labels. The
two metrics are important because multi-label algorithms may
present a different behavior in datasets with similar cardinality,
but different density.
3.1. The Portavita dataset
The Portavita dataset is a medical dataset collected during the
standard care of DT2 patients. Such a dataset includes 525 diabetic
patients affected by four complications which are: hypertension,
dyslipidemia, microvascular and macrovascular diseases. A
summary showing the distribution of the labels amongst the
patients in such a dataset is shown in Table 1.
The Portavita dataset presents a label cardinality of 2.13, a label
density of 0:532, with a total of 15 possible symbols (combination
of co-occurring labels), all occurring in the dataset. All patients
have multiple health records (>3), for an average number of
records per patient equal to 6:72 and a total number of records
equal to 3528, comprising a set of common laboratory tests and
physical examinations that are part of normal routine tests in
DT2. Table 2 gives a summary of the descriptive statistics of such
laboratory tests.
Depending on the stability of the diabetic patient physiological
values, the data may be collected once every six months, or once
every three months, to check for the presence of microvascular
or macrovascular complications.
As this is a real world dataset, the presence of a label may
simply point towards a suspected issues, requiring further labora-
tory tests before it can be conﬁrmed. In other cases, the label is
assigned at the beginning of the treatment, and then it is never
removed even if the patient does not present the complication
any more.
We can calculate that the prior probability for a patient to
present a label to be 53.33% for each label, which represents a base
average precision to compare against with the attemptedTable 1
Distribution of labels in the Portavita dataset.
Label Number of patients %
Hypertension 280 53.33
Dyslipidemia 280 53.33
Microvascular 280 53.33
Macrovascular 280 53.33classiﬁers. In the Portavita dataset, the tests are performed with
a frequency of 3/6 months for most of the features, which are
conducted at the same time for each patient, and consequently, it
is quite easy to produce a set of vectors and to go from the
relational model to the multivariate time series associated to a
patient for this dataset.
3.2. MIMIC II dataset
As a second dataset for our study, we decided to use an extrac-
tion of 2635 patients from the MIMIC II database. Since MIMIC II is
a large database, we decided to select patients that had more than
40 records. Our selection has an average of 60:39 records and a
total of 159,127 records. The chronic illnesses and number of
patients per illness in MIMIC II dataset are shown in Table 3.
The MIMIC II dataset has a label cardinality of 2:54 and a label
density of 0:254, with 1023 possible symbols, of which 194 are
present in the dataset. The patients of MIMIC II are very different
from those of Portavita, as MIMIC II is focused on intensive care
patients, while Portavita’s patients are standard care patients. This
also implies that there are more laboratory tests collected per
patient in MIMIC II than in Portavita.
In MIMIC II the frequencies of the laboratory tests depend on
the gravity of the patient and not on a treatment. We transformed
the patients’ records in multivariate time series by taking the sam-
ple frequency of the most frequent laboratory tests for each patient
(for example, glucose in serum) and we applied a last observation
carried forward (LOCF) to the less frequent measurements consid-
ering them as constant between two measurements. We are aware
that LOCF underestimates the variability of the data. Our simplify-
ing assumption in applying LOCF is that if the variability between
measurements of such values was not crucial for the caregivers of
the intensive care units in the ﬁrst place, then it is acceptable to
underestimate variability in our classiﬁcation analysis. Validating
approaches to handle data sampled with different frequencies is
an interesting problem that we cannot exhaust within a single con-
tribution, and therefore will be subject of future work.
For those data that are completely missing, we applied the
imputation approach explained in the next Section.
The descriptive statistics of MIMIC II dataset, are shown in
Table 4. In MIMIC II case, the descriptive statistics for the physio-
logical values are calculated before the LOCF procedure. The miss-
ing values rates are calculated after LOCF. A difference between
Portavita and MIMIC II datasets is that Portavita has a balanced dis-
tribution of labels, whereas in MIMIC II the patient populations are
imbalanced. Additionally the two datasets differ in label density.
Another difference is that Portavita has a time granularity of
months, whereas the tests are performed multiple times per day
in MIMIC II. Finally, Portavita has way more missing values than
MIMIC II. These differences will allow us to evaluate the considered
algorithms in diverse settings and thus also highlight their
strengths and weaknesses.
3.3. Missing value imputation
For both of the datasets, the multivariate time series present
missing values. In medical datasets, the missing at random
assumption does not hold, since if a patient presents missing val-
ues for a test, it is often because there was no medical reason to
perform it. Thus, removing patients with many missing values
would bias the study towards patients with more recognized med-
ical conditions. Similarly, removing features with many missing
values implies losing information about the status of the patients.
In the Portavita dataset, some of the features are missing more
than 90% of the values. This is quite a normal situation in real
world standard care datasets, as the patients considered may have
Table 2
Portavita dataset descriptive statistics.
Test name Frequency MEAN MEDIAN MIN MAX SD % Missing values
BMI (kg/cm2) Each visit 29.79 29.00 16.00 49.00 5.20 0.00
Body Weight (g) Each visit 85.17 84.00 35.00 189.00 16.99 0.00
Heart-rate (bpm) 3/6 months 72.83 72.00 60.00 360.00 11.26 35.44
Height (cm) Once 169.04 169.00 130.00 270.00 9.95 52.33
Abdominal circumference (cm) 3/6 months 103.03 102.00 75.00 189.00 13.57 84.17
Diastolic blood pressure (mmHg) 3/6 months 78.24 80.00 60.00 180.00 9.81 7.61
Systolic blood pressure (mmHg) 3/6 months 138.07 138.00 100.00 270.00 17.69 7.90
HDL-cholesterol (mg/dL) 3/6 months 1.22 1.20 0.09 9.30 0.34 2.58
LDL-cholesterol (mg/dL) 3/6 months 2.72 2.60 0.30 17.20 0.98 5.09
HbA1c (mg/dL) 6 months 52.29 50.00 5.30 180.00 12.91 16.27
Total Chol/HDL-Chol ratio 3/6 months 4.15 3.90 1.30 27.30 1.35 4.05
Albumine/Creatinine ratio 3/6 months 5.05 1.10 0.40 939.20 18.56 49.04
Aspartate Transaminase (IU/L) 3/6 months 33.60 24.00 5.00 2985.00 71.38 91.52
Natrium (mmol/L) 3/6 months 139.73 140.00 116.00 165.00 2.84 60.26
Kalium (mmol/L) 3/6 months 4.35 4.30 2.20 7.80 0.47 39.74
Creatinine in Urine (mg/dL) 3/6 months 79.90 75.00 8.00 1085.00 29.52 18.19
Albumine in Urine (mg/dL) 3/6 months 30.81 8.00 0.60 1000.00 82.54 46.27
Hemoglobin (g/dl) 3/6 months 8.40 8.50 2.90 12.30 1.07 80.82
Fasting Glucose (mmol/L) 3 months 7.61 7.20 1.30 42.60 2.15 14.48
Alanine Transaminase (IU/L) 3/6 months 32.00 25.00 4.00 2510.00 42.81 76.53
GammaGT (IU/L) 3/6 months 61.99 35.00 4.00 2855.00 104.82 87.24
Creatinine Kinase (IU/L) 3/6 months 128.42 91.00 8.00 5750.00 176.33 92.46
Total Cholesterol (mmol/L) 3/6 months 4.80 4.70 1.30 33.30 1.16 2.55
Triglyceride (mmol/L) 3/6 months 1.94 1.62 0.12 87.05 1.49 2.84
Cockcroft (mL/min) variable 90.35 84.00 6.00 4356.00 94.03 53.32
Glucose after Meal (mmol/L) 3 months 9.03 8.20 1.20 61.00 3.68 90.68
Modiﬁcation of Diet in Renal Disease (mL/min) Variable 85.02 84.00 3.00 974.00 26.29 33.29
Table 3
Distribution of labels in the MIMIC II dataset.
Label Number of patients %
Thyroid disease 297 11.2
Diabetes mellitus 875 33.2
Lipoid metabolism disease 671 25.4
Fluid electrolyte disease 1014 38.4
Hypertensive disease 1568 59.5
Thrombosis 180 6.8
Hypotension 294 11.1
COPD 573 21.7
Liver Disease 208 7.8
Kidney Disease 1013 38.4
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rithms must be robust to large amounts of missing values and still
be able to generalize with respect to unseen data.
It is well known that there is not a single universal approach to
deal with missing values [24] in medical datasets. One of the most
used approaches is to substitute the mean for the missing values
[25], but this is rarely considered acceptable [26]. A more accept-
able approach is to use medical knowledge to substitute with val-
ues within a likely range [26]. With respect to the mean
imputation, this avoids the misleading effect of considering ill
someone due to imputing values out of normal ranges.
Given these considerations, we performed plausible physiolog-
ical values imputation in our multi-label classiﬁcation analysis. We
either impute physiological values in ranges that are likely for the
given patient illnesses (putting high blood pressure if the patient
has hypertension) or we impute physiological values of a healthy
person when the related illness label is absent (normal blood pres-
sure if the patient has not hypertension).4. Methods
In this section we illustrate how we apply a set of multi-label
classiﬁcation algorithms to the selected medical discrete time
series datasets.For each of the algorithms selected we apply the following steps
on the data: after transforming our data from medical records to
multivariate time series as described in Section 3, we standardize
the data to have the same contribution for each feature, we apply
a BoW quantization and we standardize the data again to have the
same contribution for each codeword. Then, for dimensionality
reduction approaches, we apply a dimensionality reduction
algorithm and we use a nearest centroid classiﬁer based on the
cosine distance. For standard multi-label classiﬁers, we apply the
multi-label classiﬁcation algorithm after the second standardiza-
tion step. Fig. 1, inspired by the work of Wang et al. in [7],
illustrates the main steps applied by our system in the speciﬁc case
of KLFDA. For the comparison, we chose the following algorithms,
all applied on the model calculated with BoW:
 BoW Cosine: This technique applies the cosine distance on the
patient histograms and it represents the baseline for the
comparison.
 LDA-BR, KDA-BR and KLFDA-BR: Linear Discriminant Analysis
[27], Kernel Discriminant Analysis and Kernel Local Fisher
Discriminant Analysis, with a binary relevance approach, where
the classes of the patients are those explained in Section 3.
 LDA, KDA and KLFDA: The same as above, but concatenating the
features.
 MLkNN, DMLkNN, BPMLL, BR-SVM: Multi-label k-nearest
neighbors [18], dependent multi-label k-nearest neighbors
[28], back propagation multi-label learning [29] and multi-label
support vector machines with a binary relevance approach [30].
We purposely decided to use multi-label algorithms capable of
handling non-linearly separable data to conﬁrm our hypothesis
that supervised dimensionality reduction algorithms such as
KLFDA and KDA are suitable candidates for multi-label learning
in medical time series. In the rest of this Section we explain how
we apply the BoW algorithm, the nearest centroid classiﬁer and
ﬁnally the metrics used for the evaluation of the multi-label
classiﬁers.
Table 4
Mimic II dataset descriptive statistics.
Test name MEAN MEDIAN MIN MAX SD % Missing val
Hematocrit of Blood (volume fraction) 31.19 30.70 2.00 67.70 4.94 0.25
Platelets in Blood (103/uL) 241.26 218.00 5.00 3162.00 151.43 0.27
Leukocytes in Blood (103/uL) 10.22 8.90 0.10 303.90 7.38 0.3
Hemoglobin in Blood (mmol/L) 10.51 10.30 0.00 23.80 1.70 0.3
Erythrocyte mean corpuscular volume (fL) 90.13 90.00 0.00 139.00 6.84 0.31
Erythrocytes in Blood (103/uL) 3.51 3.45 0.00 7.39 0.61 0.31
Erythrocyte mean corpuscular hemoglobin concentration (g/dL) 33.39 33.40 0.00 39.70 1.57 0.31
Erythrocyte mean corpuscular hemoglobin (pg/cell) 30.07 30.10 0.00 46.10 2.54 0.31
Erythrocyte distribution width (Ratio) 16.07 15.60 0.00 35.00 2.34 0.32
Urea nitrogen in Serum or Plasma (mg/dL) 32.18 25.00 1.00 280.00 23.89 0.33
Creatinine in Serum or Plasma (mg/dL) 1.81 1.10 0.00 73.00 1.92 0.33
Potassium in Serum or Plasma (mg/dL) 4.18 4.10 1.40 13.80 0.67 0.61
Sodium in Serum or Plasma (mEq/L) 138.52 139.00 102.00 180.00 4.94 0.68
Chloride in Blood (mEq/L) 103.12 103.00 59.00 141.00 6.18 0.69
Bicarbonate in Serum (mEq/L) 25.41 25.00 4.00 65.00 4.97 0.69
Anion gap in Blood (mEq/L) 14.22 14.00 0.00 117.00 3.90 0.71
Glucose in Serum or Plasma (mg/dL) 130.59 116.00 4.00 2220.00 63.80 0.71
Magnesium in Serum or Plasma (mg/dL) 2.01 2.00 0.20 25.20 0.37 2.16
INR in Blood by Coagulation assay 1.74 1.40 0.00 88.60 1.47 2.71
Prothrombin time (PT) in Blood by Coagulation assay 16.89 14.60 7.00 150.00 7.09 2.74
Activated partial thrombplastin time (aPTT) in Blood by Coagulation assay 44.94 35.30 16.40 193.30 25.71 2.94
Phosphate in Serum or Plasma (mg/dL) 3.75 3.50 0.30 22.60 1.41 4.36
Calcium [Mass/volume] in Serum or Plasma (mg/dL) 8.56 8.50 0.30 25.40 0.83 4.54
pH of Urine 5.88 5.50 5.00 9.00 0.99 15.3
Urobilinogen in Urine (mg/dL) 1.79 1.00 0.20 12.00 2.61 15.3
Ketones in Urine (mg/dL) 48.93 15.00 10.00 150.00 49.13 15.3
Speciﬁc gravity of Urine by Test strip 1.02 1.02 1.00 1.08 0.01 15.3
Protein in Urine by Test strip (mg in 24 h) 106.39 30.00 15.00 500.00 146.79 15.3
Glucose in Urine by Test strip (mg in 24 h) 461.21 250.00 70.00 1000.00 401.51 15.3
Fig. 1. BoW with kernel methods.
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The BoW model was originally introduced for text document
analysis [31]. In document retrieval a codebook is deﬁned as a set
of pre-selected words, also called codewords. The BoW method
counts the codewords per document, reducing each document to
a histogram. Adapted versions of the BoW model have been
recently applied in the ﬁeld of computer vision for image classiﬁ-
cation [32,33], and for biomedical time series classiﬁcation [7].
When the entities to be analyzed are not documents, but are irreg-
ular time series of continuous physiological values, the codebook
of the BoW model can be deﬁned using a clustering algorithm. In
this paper, the k-means algorithm [34] is used to cluster the mul-
tivariate time series obtained from the health records as explained
in Section 3, associated to the patients to create a set of centroids.
These centroids then become the codewords retained in the
codebook.
More formally, if we have a set of health records
X ¼ ½x1; x2; . . . ; xn, with xi 2 Rd, where d are numerical features of
each record, associated to a set of patients P, where each patient
can have more than one record, and a set of clustering centers
ci 2 ½c1; . . . ; ch calculated with k-means and representing the
codebook, then we can set an un-normalized feature f, in an un-
normalized histogram u, for f ¼ 1; . . . ; jPj, as:
uf ¼
XPr
i¼1
kxi  cf k2 ð15Þ
where Pr is the number of records associated to a patient, and k  k2
is the euclidean norm. After calculating u, we can calculate a nor-
malized histogram h, as:
hf ¼ ufkuk2
ð16Þ
for f ¼ 1; . . . ; jPj. Each patient is then represented in terms of a
normalized histogram, allowing us to compare patients even if they
have a different number of records.
4.2. Nearest centroid classiﬁcation and label ranking
To classify a new element x we ﬁrst use the eigenvectors com-
puted with KLFDA to project the testing sample in the identiﬁed
subspace for a given label k:
x^ðkÞ ¼ TðkÞopt  /ðxÞ ð17Þ
where x^ðkÞ is the projected testing sample using the transformation
matrix TðkÞopt , calculated for label k, on the mapping /ðxÞ.
Second, we concatenate all the test sample projections for each
of the labels in a single vector:
^^x ¼ ðx^ð1Þjx^ð2Þj . . . jx^ðkÞÞ ð18Þ
The possibility to concatenate features is a big advantage of
dimensionality reduction approaches such as KDA and KLFDA as it
allows us to deﬁne an easy way to chain the features calculated
by the different classiﬁers, without the need to train another classi-
ﬁer recursively as it happens with classiﬁer chains (CC).
Third, we calculate a cosine distance between the mean of the
projected training elements and the projected testing element for
each of the labels.
dk ¼ cosð^^x;lkÞ ¼
^^x  lk
k^^xkklkk
ð19Þ
where lk represent the mean of the concatenation of the features of
the training elements in the projected space belonging to label k. Todecide whether an element has a label or not, we perform the
following test:
y^k ¼
1 if dk < dk;
0 otherwise

ð20Þ
Finally, we can deﬁne the ranking function rankf ð^^x; kÞ for label k as:
rankf ð^^x; kÞ ¼ 1 dkdk þ dk ð21Þ4.3. Multi-label metrics
As stated in [18,35], multi-label performance metrics differ
from single label ones. Following the same approach presented in
[36,18], we propose the following ﬁve evaluation metrics for
multi-label learning.
Let a testing set S ¼ fðx1;Y1Þ; ðx2;Y2Þ; . . . ; ðxm;YmÞg.
Hamming loss: evaluates howmany times an observation-label
pair is misclassiﬁed. The score lies between 0 and 1, where 0 is the
best:
hlossSðhÞ ¼ 1m
Xm
i¼1
jhðxiÞMYij
jLj ð22Þ
One-error: evaluates how many times the top-ranked label is
not in the set of proper labels of the observation. The score lies
between 0 and 1, where 0 is the best:
one errorSðf Þ ¼ 1m
Xm
i¼1
cðargmax
y2L
f ðxi; yÞÞ; ð23Þ
where
cðyÞ ¼ 1 if y R Yi;
0 otherwise:

ð24Þ
Coverage: evaluates how far on average we need to traverse the
list of labels in order to cover all the proper labels of the observa-
tion. A score as small as possible is better:
coverageSðf Þ ¼
1
m
Xm
i¼1
max
y2Yi
rankf ðxi; yÞ  1: ð25Þ
Ranking loss: evaluates the average part of label pairs that are
ordered in reverse for the observation. The score lies between 0
and 1, where 0 is the best:
rlossSðf Þ ¼ 1m
Xm
i¼1
1
jYijjðL n YiÞj  jfðy1; y2Þjf ðxi; y1Þ
6 f ðxi; y2Þ; ðy1; y2Þ 2 Yi  ðL n YiÞgj ð26Þ
Average precision: evaluates the average fraction of labels
ranked above a particular label y 2 Yi which actually are in Yi.
The score lies between 0 and 1, where 1 is the best:
avgprecSðf Þ ¼
1
m
Xm
i¼1
1
jYij

X
y2Yi
jfy0jrankf ðxi; y0Þ 6 rankf ðxi; yÞ; y0 2 Yigj
rankf ðxi; yÞ : ð27Þ
where M represents the symmetric difference, and n is the set-
theoretic difference.
5. Results
In this section we evaluate the combination of BoW and multi-
label classiﬁcation algorithms. In the Portavita dataset, we perform
our evaluation using a leave-one-patient-out cross validation
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[37], as it avoids situations that happen with leave-one-out (LOO),
where records of the same patient are both in the training and test-
ing set. Furthermore, LOPO CV presents an advantage with respect
to N-folds CV, in which the selection of the random splits may lead
to choose suboptimal parameters. Given the fact that we have 525
patients and 3528 health records, the computational cost of LOPO
CV is affordable for the Portavita dataset. For model selection, we
split our dataset into a training/validation set and a testing set,
applying a LOPO CV on the training/validation set to select the best
model for the testing phase. We withheld 375 patients for the
training/validation and 150 patients for the testing.
Concerning the MIMIC II dataset extraction, we used a 10-fold
CV approach for the grid search, splitting the dataset and keeping
70% of the patients (1844) for training and validation and 30%
(791) patients for testing, while keeping the same distribution of
labels in the test dataset. 10-folds CV was chosen as this dataset
counts 2635 patients for a total of 159,127 health records, and
LOPO CV was computationally infeasible to run a grid search.
5.1. Parameters selection with CV
The combination of BoW and dimensionality reduction tech-
niques involves many parameters: size of the codebook, neighbors
for the afﬁnity matrix, the regularization coefﬁcient, and the num-
ber of components to retain in the dimensionality reduction. Given
the large amount of parameters to evaluate, we decided to run a
grid search with a step of 100 for the size of the codebook, identi-
fying cb ¼ 600 as the best size for the codebook for all the consid-
ered algorithms in the Portavita dataset and cb ¼ 800 for the
MIMIC II dataset.
After the dimensionality reduction applied by LDA, KDA, and
KLFDA, we always retain components that can explain at least
99% of the variance of the model. Fig. 2 shows the grid search on
average precision and hamming loss, run on the training set, for
the other parameters of KLFDA in the Portavita dataset.
Table 5 summarizes the parameters selection performed with
LOPO CV and 10-fold cross validation concerning the algorithms
studied for the Portavita and MIMIC II datasets. The parameter N
identiﬁes the number of neighbors, while k identiﬁes the regulari-
zation factor, r the smoothing parameter for MLkNN and DMLkNN,
c the exponent of the RBF kernel, and HN the number of hidden
nodes in the BPMLL algorithm. In particular, the most difﬁcult algo-
rithm to train has been BPMLL as it requires more parameters than
the other algorithms. To simplify the search, we decided to keep
the learning rate constant to the default value a ¼ 0:05.
5.2. Results on the Portavita dataset
After training and validation of the model, we perform our test-
ing using 150 additional patients from the Portavita dataset, withFig. 2. Grid search on hamming lossrespect to the performancemeasures discussed in Section 4. Table 6
shows the results for the selected algorithms on the Portavita data-
set, with a conﬁdence interval of 95%. The BoW Cosine approach is
taken as a baseline for the comparison with the other algorithms.
The classes of patients of the Portavita dataset do not appear to
be linearly separable and linear techniques such as LDA and LDA-
BR do not seem to improve the results with respect to a BoW clas-
siﬁer. We think that this is due to the tendency of non-regularized
LDA to overﬁt when the ratio between the classes and the features
of the training elements is small [38,39].
KLFDA and KDA with feature concatenation achieve a better
hamming and ranking loss than the other considered algorithms.
KLFDA also achieves a better average precision. This suggests that
in the case of classifying patients affected by DT2, the possibility of
using supervised kernel methods and LPP brings an advantage in
terms of classiﬁcation. Another advantage of both KDA and KLFDA
when compared to the other considered algorithms is the possibil-
ity of concatenating the projected features calculated by each of
the classiﬁers. The KLFDA-BR and KDA-BR algorithms, on the con-
trary, do not perform much better than the standard BoW
approach. In particular KDA-BR performs exactly the same as the
BoW case. This is probably due to the fact that the relationship
between the labels is not taken into consideration, degrading per-
formances. KLFDA-BR shows an improvement with respect to BoW.
This suggests that algorithms considering the locality of the data
are likely to perform better than algorithms considering only the
labels.
MLkNN performs similarly to KDA and KLFDA, with the best
one-error score, conﬁrming that making use of neighborhood prop-
erties of the dataset is quite important in the case of DT2 patients.
In contrast, BPMLL does not generalize too well with respect to
new data after the training. The main issue of BPMLL is the large
number of parameters to train, which makes it difﬁcult to tune
properly. Furthermore, BPMLL seems to be affected more by the
large rate of missing values in the Portavita dataset than the other
considered algorithms.
BR-SVM performs well in both training and testing, despite not
considering the interaction between the labels, which seems to
explain the difference in performance with KLFDA concerning
hamming loss and ranking loss.5.3. Results on the MIMIC II dataset
Table 7 shows the results for the selected algorithms on the
MIMIC II dataset, with a conﬁdence interval of 95%. As it is clear
from Table 7, BoW without any transformation is affected by the
curse of dimensionality and LDA-BR does not really give meaning-
ful results. LDA manages to improve the results with respect to
BoW, but as in the Portavita dataset, the algorithm does not
perform well.and average precision for KLFDA.
Table 5
Selected parameters.
Algorithm Parameters Portavita Parameters MIMIC II Interval Step
KDA-BR k ¼ 40, cb = 600 k ¼ 10, cb = 800 [1:50], [102 : 103] lin, lin
KDA k ¼ 49, cb = 600 k ¼ 20, cb = 800 [1:50], [102 : 103] lin, lin
KLFDA-BR N = 30, k ¼ 5, cb = 600 N = 40, k ¼ 3, cb = 800 [1:50], [1:50], [102 : 103] lin, lin, lin
KLFDA N = 34, k ¼ 9, cb = 600 N = 47, k ¼ 3, cb = 800 [1:50], [1:50], [102 : 103] lin, lin, lin
MLkNN N = 29, r ¼ 2, cb = 600 N = 19, r ¼ 3, cb = 800 [1:50], [1:50], [102 : 103] lin, lin, lin
DMLkNN N = 29, r ¼ 12, cb = 600 N = 19,r ¼ 5, cb = 800 [1:50], [1:50], [102 : 103] lin, lin, lin
BPMLL k ¼ 106, HN = 5, cb = 600 k ¼ 107, HN = 7, cb = 800 [108:1], [1:20], [102 : 103] log, lin, lin
BR-SVM C = 10, c ¼ 101, cb = 600 C = 5, c ¼ 1, cb = 800 [1:102], [103 : 103], [102 : 103] lin, log, lin
Table 6
Results for the Portavita dataset. Values in bold identify the best result for a given metric.
Algorithm/metric Average precision Hamming loss Ranking loss Coverage One-error
BoW 68% ± 4% 51.6% ± 4.2% 50% ± 5.6% 2.2 ± 0.14 50% ± 7.8%
LDA 67.8% ± 4% 51.1% ± 4.3% 51.9% ± 5.7% 2.3 ± 0.14 48% ± 8%
LDA-BR 67% ± 4% 52.8% ± 4.3% 52.2% ± 5.8% 2.3 ± 0.14 48% ± 8%
KDA-BR 67.8% ± 3.8% 57.5% ± 3.2% 58% ± 3.9% 2.25 ± 0.15 48% ± 8%
KDA 78.3% ± 3.8% 39.1% ± 4.1% 33.4% ± 5.5% 1.94 ± 0.16 32.1% ± 7.5%
KLFDA-BR 73.5% ± 3.8% 41.6% ± 3.5% 38.9% ± 5.2% 2.07 ± 0.16 35.7% ± 7.7%
KLFDA 78.8% ± 3.7% 37.3% ± 4% 32.2% ± 5.2% 1.87 ± 0.16 32.1% ± 7.5%
MLkNN 78.2% ± 3.7% 44% ± 3.8% 36 ± 5.5% 2 ± 0.16 30% ± 7.5%
DMLkNN 76.1% ± 3.8% 44.8% ± 3.8% 37% ± 5.4% 2.1 ± 0.15 33.3% ± 7.5%
BPMLL 75.7% ± 3.8% 42.6% ± 4.1% 38.3% ± 5.6% 2 ± 0.16 36% ± 7.7%
BR-SVM 78.2% ± 3.7% 39.3% ± 4.2% 34% ± 5.3% 1.98 ± 0.16 33.3% ± 7.5%
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best performing algorithms are MLkNN and DMLkNN, while
the KDA and KLFDA algorithms perform similarly to MLkNN
and DMLkNN. The fact that MIMIC II dataset has less missing
values than Portavita, seems to favor the BPMLL algorithm,
which performs well from the perspective of the average preci-
sion. BPMLL still does not perform well for the hamming loss
and the ranking loss, which we believe related to the difﬁculty
in training the algorithm.
Second, binary relevance approaches seem to perform well on
MIMIC II, except for BR-SVM. KDA-BR performs similarly to
KLFDA-BR: this may happen because MIMIC II has 194 different
symbols, and thus the interaction between the illnesses is quite
complex, limiting the advantage of LPP projections. Furthermore,
KDA-BR and KLFDA-BR seem to have comparable results to KLFDA
and KDA, where the calculated features are concatenated. This may
be related to the fact that MIMIC II is imbalanced. Concatenating
features moves the centroid of a label depending on the features
calculated for the other labels, but majority labels may have more
impact in deﬁning the centroids, degrading the performance. The
difference in performance between BR-SVM, KDA-BR and KLFDA-
BR is of more difﬁcult interpretation. This could be caused by theTable 7
Results for the MIMIC II dataset. Values in bold identify the best result for a given metric
Algorithm/metric Average precision Hamming loss
BoW 47.5% ± 1.6% 44.5% ± 1.1%
LDA 50.9% ± 1.6% 42.7% ± 1.1%
LDA-BR 43.3% ± 1.4% 40.2% ± 0.8%
KDA-BR 64.74% ± 1.8% 23.7% ± 1.2%
KDA 66% ± 1.8% 23.4% ± 0.9%
KLFDA-BR 64.79% ± 1.8% 23.8% ± 1.1%
KLFDA 65.5% ± 1.8% 23.3% ± 0.9%
MLkNN 68.4% ± 1.8% 21.7% ± 1%
DMLkNN 68.1% ± 3.8% 21.6% ± 0.8%
BPMLL 67.8% ± 1% 26% ± 0.8%
BR-SVM 57.7% ± 1.8% 22.2% ± 0.9%use of regularization or of the nearest centroid classiﬁer in KDA-
BR and KLFDA-BR algorithms.
5.4. Discussion
The fact that KLFDA and KDA perform better than the other
algorithms for the Portavita dataset in respect to hamming loss
and ranking loss is quite important in medical applications such
as classiﬁcation of diabetic patients complications. Hamming loss
discriminates the capability of the algorithm to identify the
presence of a complication, while ranking loss discriminates how
well the algorithm ranks the labels. These metrics allow a caregiver
to understand which patient illnesses have a strong expression,
giving an indication on where to act more promptly.
The performed evaluation illustrates the strengths and
weaknesses of KDA and KLFDA for multi-label classiﬁcation tasks:
the behavior of KDA and KLFDA is comparable with that of state-
of-the-art multi-label classiﬁcation algorithms, but they seem to
present an advantage with respect to datasets with a large number
of missing values and with a high label density such as the Portavita
dataset.We can have a better idea of the behavior of KDA and KLFDA
by looking at Table 8, comparing the hamming loss per symbol of.
Ranking loss Coverage One-error
39.5% ± 1.6% 5.6 ± 0.14 69% ± 3.4%
38.2% ± 1.5% 5.4 ± 0.17 63.2% ± 3.3%
39.2% ± 1.4% 5.14 ± 0.15 82.93% ± 2.5%
26% ± 1.4% 4.67 ± 0.19 39.7% ± 3.3%
23.2% ± 1.4% 4.2 ± 0.18 40.5% ± 3.3%
25.9% ± 1.4% 4.59 ± 0.18 40% ± 3.4%
23.7% ± 1.4% 4.25 ± 0.16 41.1% ± 3.3%
20% ± 1.5% 4 ± 0.17 35.6% ± 3%
21.5% ± 1.5% 4 ± 0.17 34.1% ± 3.2%
37.1% ± 3.3% 4 ± 0.18 37% ± 3.3%
37% ± 1% 5.8 ± 0.19 38.6% ± 3.2%
Table 8
Hamming loss per symbol in the Portavita dataset. H = Hypertension, D = Dyslipidemia,
Mi = Microvascular, Ma = Macrovascular.
Symbol H D Mi Ma KLFDA
(%)
KDA
(%)
BR-SVM
(%)
MLkNN
(%)
1 No No No Yes 40 42.5 60 60
2 No No Yes No 40 35 47.5 50
3 No No Yes Yes 40 45 42.5 42.5
4 No Yes No No 25 32.5 27.5 40
5 No Yes No Yes 42.5 45 40 42.5
6 No Yes Yes No 20 15 15 30
7 No Yes Yes Yes 40 40 42.5 42.5
8 Yes No No No 35 32.5 40 45
9 Yes No No Yes 40 40 45 57.5
10 Yes No Yes No 47.5 57.5 47.5 42.5
11 Yes No Yes Yes 45 40 62.5 52.5
12 Yes Yes No No 27.5 40 20 40
13 Yes Yes No Yes 40 40 40 42.5
14 Yes Yes Yes No 35 37.5 30 30
15 Yes Yes Yes Yes 42.5 40 30 42.5
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dence intervals are omitted as we only have 10 elements per
symbol).
In these results, we see that KDA has an advantage where the
patients have only one label, which are also those patients present-
ing many missing values in Portavita dataset. For the other classes,
KDA performs similarly to BR-SVM, with some exceptions, proba-
bly caused by the fact that BR-SVM ﬁnds support vectors, whereas
KDA is a variance based method. KLFDA seems to combine the
behavior of KDA, BR-SVM and MLkNN: the eigenvectors explaining
little variance are discarded just like in KDA; the use of kernel
methods allows KLFDA to deal with non-linearity in the data, sim-
ilarly to BR-SVM; the LPP transformation allows KLFDA to consider
the neighborhood of the elements, similarly to MLkNN, but in addi-
tion if there are enough elements per symbol, with a high label
density, the retained eigenvectors would be able to characterize
those symbols expressing most variance. In this sense, when deal-
ing with datasets presenting the three aspects of missing data, high
label density and non-linearity, KLFDA may have an advantage
with respect to other techniques.
In MIMIC II, KLFDA and KDA perform slightly worse on the aver-
age precision than MLkNN and DMLkNN, but they are comparable
for hamming loss and ranking loss. A possible reason for this is that
MIMIC II dataset is imbalanced. KLFDA and KDA are variance based
methods, so an imbalanced estimation of the classes variance
impacts the calculated model and its performance. Looking at the
hamming loss per symbol in MIMIC II, we found that the absence
of missing values in MIMIC II, cancels the advantage of KLFDA
and KDA, as they behave similarly to MLkNN for patients with only
one complication. Additionally, MIMIC II has a low label density,
with 194 symbols and few patients for most of the symbols, which
may be difﬁcult to characterize for the variance based model calcu-
lated by KLFDA and KDA. If this is the case, only the effect of the
LPP projection of KLFDA, and of the nearest centroid classiﬁer for
KLFDA and KDA would be present and that would explain the sim-
ilar behavior of KLFDA and KDA with MlKNN.
Finally, an advantage of KLFDA and KDA it that they compute a
model based on eigenvectors, which allows to include new
patients’ records by projecting their BoW representation and then
recalculating the centroids for each class, while MLkNN and
DMLkNN have to store the new instances in memory, that is infea-
sible with big datasets.6. Conclusions
In this paper we studied the combination of the BoW model in
medical time series with dimensionality reduction approaches formulti-label patient classiﬁcation. When taking the Portavita data-
set into consideration, the KLFDA algorithmwith a nearest centroid
classiﬁer achieves the best results. In the MIMIC II dataset, dimen-
sionality reduction algorithms are comparable to state-of-the-art
multi-label classiﬁcation algorithms, but suffer from the fact that
the dataset is imbalanced.
There are several possible extensions to this work. At the
moment we are using a single kernel mapping, but extensions of
KLFDA and KDA that work with multiple kernel learning have
already been deﬁned [40]. Multiple kernels could achieve a better
mapping for our data and improve the precision of KLFDA and KDA.
Another promising approach could be to develop a multi-label
version of KLFDA and KDA, similarly to what is proposed in [41].
This would require modifying the deﬁnition of the scatter matrices
in KLFDA and KDA to consider multiple labels, which is quite a
challenging problem.
In Section 3, we identiﬁed the issue of dealing with values
sampled at different frequencies. Quantizing patient data with dif-
ferent sampling frequencies or considering descriptive statistics
rather than a codebook, could be suitable approaches. Finally, we
could apply a different substitution to LOCF and generate physio-
logical values with a maximum likelihood model, provided that
enough patients’ records are available.Acknowledgments
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